Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-Related Toxicities”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Not applicableUnknownNCT02848807
What this trial is testing

Chemotherapy-related Toxicity, Nutritional Status and Quality of Life

Who this might be right for
Toxicity Due to ChemotherapyCancer CachexiaMetastatic Colorectal Cancer+2 more
University Clinical Centre, Gdansk 100
Large-scale testing (Phase 3)Study completedNCT00003600
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Who this might be right for
AnemiaBreast CancerChronic Myeloproliferative Disorders+8 more
Alliance for Clinical Trials in Oncology 344
Early research (Phase 1)Study completedNCT00039481
What this trial is testing

Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors

Who this might be right for
Cardiac ToxicityUnspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 15
Not applicableStudy completedNCT03131024
What this trial is testing

Caloric Restriction and Exercise for Protection From Anthracycline Toxic Effects

Who this might be right for
Breast Cancer Female
University of Alberta 58
Not applicableUnknownNCT04461392
What this trial is testing

Exercise Response After Revalidation in Cancer Patients

Who this might be right for
OncologyCardiac Toxicity
Universitair Ziekenhuis Brussel 191
Large-scale testing (Phase 3)UnknownNCT05728632
What this trial is testing

Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines

Who this might be right for
Breast CancerLymphoma, Large B-Cell, DiffuseCardiotoxicity+2 more
Giulio Stefanini 80
Not applicableUnknownNCT05146843
What this trial is testing

The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients

Who this might be right for
Breast Neoplasms
D'Or Institute for Research and Education 44
Not applicableStudy completedNCT06595758
What this trial is testing

This Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCR

Who this might be right for
Breast Cancer
Menoufia University 100
Not applicableStudy completedNCT00002900
What this trial is testing

SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial

Who this might be right for
Breast CancerCardiac Toxicity
SWOG Cancer Research Network 180
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Large-scale testing (Phase 3)UnknownNCT01093235
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Who this might be right for
Breast CancerCardiac ToxicityPerioperative/Postoperative Complications
Cambridge University Hospitals NHS Foundation Trust 800
Not applicableNot Yet RecruitingNCT07408362
What this trial is testing

Early Diagnosis and Cardiovascular Risk Stratification in Children Exposed to Cancer Therapies

Who this might be right for
Cancer Therapy-related Cardiovascular ToxicityChildhood CancerChemotherapeutic Toxicity+2 more
Centre Hospitalier Universitaire de Liege 100
Not applicableUnknownNCT05063760
What this trial is testing

Exercise in Testicular Germ Cell Cancer Survivors

Who this might be right for
Testicular Germ Cell Tumor
Slovak Academy of Sciences 60
Testing effectiveness (Phase 2)Study completedNCT00003089
What this trial is testing

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)UnknownNCT00003583
What this trial is testing

Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung CancerRadiation Toxicity
University of Florida 20
Not applicableStudy completedNCT04694794
What this trial is testing

Diminish Chemotherapy Related Side Effects Through Patient Education

Who this might be right for
Chemotherapeutic ToxicityChemotherapeutic Agent ToxicityChemotherapy Effect
Milton S. Hershey Medical Center 36
Testing effectiveness (Phase 2)Ended earlyNCT00751101
What this trial is testing

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityPalmar-plantar Erythrodysesthesia
University of California, San Francisco 24
Post-approval studies (Phase 4)UnknownNCT05730777
What this trial is testing

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics

Who this might be right for
Cancer Therapy-related Cardiovascular Toxicity
Peking University Third Hospital 200
Large-scale testing (Phase 3)Study completedNCT00003937
What this trial is testing

Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma

Who this might be right for
Cardiac ToxicitySarcoma
Children's Oncology Group 253
Not applicableUnknownNCT04581967
What this trial is testing

Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients

Who this might be right for
Breast Cancer Patients
Damanhour University 100
Load More Results